AQR Arbitrage’s Kite Pharma, Inc. KITE Stock Holding History

AQR Arbitrage’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-759,314	Closed	-$137M	–	409
2017 Q3	$137M	Buy	+759,314	New	+$106M	1.48%	19

AQR Arbitrage's KITE Position: Q4 2017 in Review

AQR Arbitrage sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 759,314 shares — an estimated $137M sold.

AQR Arbitrage first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $137M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

AQR Arbitrage reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
AQR Arbitrage sold 759,314 Kite Pharma, Inc. shares in Q4 2017, an estimated $137M.
AQR Arbitrage first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
AQR Arbitrage's Kite Pharma, Inc. position peaked at $137M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on AQR Arbitrage's 13F filing for Q4 2017, filed 14 Feb 2018.